Abstract:Background: Prostate cancer (PC) ranks as the fifth deadliest tumor in the world and has been regarded as a serious threat for the life and health of middle-aged and elderly men. Some studies have shown that LINC00861 regulated the anti-tumor immune response, and may have a certain impact on tumor immunotherapy. Therefore, to explore the related role of LINC00861 in PC, we detected the expression of LINC00861 in PC, and regulated the expression of LINC00861 after confirming its expression. This study aimed to explore the potential of LINC00861 in promoting the immunity of cytotoxic T cells and influencing the biological behavior of PC cells and tumor growth by regulating programmed cell death 1 ligand 1 (PD-L1).Methods: Expression of LINC00861 and PD-L1 was detected in 10 cases of PC and adjacent tissues. Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) analysis was performed to assess the expression level of LINC00861 in cancer cells. Cell lines with differential expression were selected for interference and overexpression of LINC00861, followed by grouping. The vitality of PC cells was observed, and measurements were taken for cell proliferation, migration, invasion, PD-L1, B-cell lymphoma-2 (Bcl-2), Bcl-2-associated X protein (Bax), and expression of inflammatory factors such as Interleukin (IL)-6, IL-8, and tumor necrosis factor (TNF)-alpha in the cells. To establish the subcutaneous PC tumor model, PC cells from each group were subcutaneously implanted in the right flank of BALB/c mice using 100 mu L of phosphate-buffered saline (PBS). Mouse tumor tissues were collected to observe tumor size, assess tumor-infiltrating lymphocytes, and evaluate the infiltration of cytotoxic T cells (CD3(+) and CD8(+)).Results: In PC tissues and cells, PC-3 cells were selected for subsequent experiments through cell screening. Successful transfection of LINC00861 inhibition and overexpression vectors was achieved in PC cells. Inhibiting the expression of LINC00861 upregulated the expression of PD-L1, enhanced cell growth vitality, proliferation, migration, invasion, and cytokine production capabilities, and reduced apoptosis. Overexpression reversed these effects. In in vivo experiments, inhibiting LINC00861 expression resulted in rapid tumor growth, accompanied by increased tumor volume and dense tumor tissue cells. Overexpression of LINC00861 produced the opposite results for these effects. The findings also indicated that inhibiting LINC00861 led to a significant increase in PD-L1 expression in tumor tissues and a significant decrease in CD3(+) T and CD8(+) T levels (p < 0.05). When LINC00861 was overexpressed, PD-L1 levels were reduced, while CD3(+) T and CD8(+) T levels were improved.Conclusions: LINC00861 is down-regulated in PC tissues. The inhibition of LINC00861 increases the expression of PD-L1, inhibits cytotoxic T cells immunity, and enhances the growth of PC cells and tumor growth and metastasis. Overexpression inhibits the development of PC.

Suppression of Bcl-xL Expression by a Novel Tumor-Specific RNA Interference System Inhibits Proliferation and Enhances Radiosensitivity in Prostatic Carcinoma Cells

Suppressing the growth of rectal cancer xenografts derived from patient tumors by an adenovector expressing small hairpin RNA targeting Bcl-XL.

Nonconserved Mir‐608 Suppresses Prostate Cancer Progression Through RAC2/PAK4/LIMK1 and BCL2L1/caspase‐3 Pathways by Targeting the 3′‐utrs of RAC2/BCL2L1 and the Coding Region of PAK4

Adenovirus-mediated Sirna Targeting Bcl-xL Inhibits Proliferation, Reduces Invasion and Enhances Radiosensitivity of Human Colorectal Cancer Cells.

RNA Interference Targeting Mutant P53 Inhibits Growth and Induces Apoptosis in DU145 Human Prostate Cancer Cells

Relb Regulates Bcl-Xl Expression And The Irradiation-Induced Apoptosis Of Murine Prostate Cancer Cells

Effects of silencing B-cell specific moloney leukemia virus insertion site 1 gene by RNA inerference on proliferation and apoptosis of prostate cancer cell line PC-3

Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity

Inhibition of Bcl-2 Expression by a Novel Tumor-Specific RNA Interference System Increases Chemosensitivity to 5-Fluorouracil in Hela Cells

Enhanced tumor suppression in vitro and in vivo by co-expression of survivin-specific siRNA and wild-type p53 protein

[Biological Implications of the Inhibition of Survivin by RNA Interference in Human Androgen-Independent Prostate Carcinoma with Highly Metastatic Potential].

LINC00861 Promotes Immune Response in the Tumor Microenvironment and Inhibits Prostate Cancer Tumor Growth by Regulating PD-L1

Suppression of PC-1/PrLZ sensitizes prostate cancer cells to ionizing radiation by attenuating DNA damage repair and inducing autophagic cell death.

[The Expression and Function of Anti-Apoptotic Bfl-1 in Prostate Cancer].

Bcl-2 Gene Silencing by RNA Interference Inhibits the Growth of the Human Gallbladder Carcinoma Cell Line GBC-SD in Vitro and in Vivo

[RNA Interference of RelB Enhances the Radiosensitivity of Prostate Cancer Cell Line RM-1 in Mice].

RNA interference remarkably suppresses bcl-2 gene expression in cancer cells in vitro and in vivo.

Antitumor effects of silencing Survivin and Livin gene in prostate cancer cell PC3

Targeting Survivin Using a Combination of Mir-494 and Survivin Shrna Has Synergistic Effects on the Suppression of Prostate Cancer Growth

Overexpression Of Bcl-X-L Underlies The Molecular Basis For Resistance To Staurosporine-Induced Apoptosis In Pc-3 Cells

Inhibitory Effect of Survivin-Sirna on Prostatic Subcutaneous Xenografts in Nude Mice